Detalhe da pesquisa
1.
Venous and Arterial Thrombosis in Patients with VEXAS Syndrome.
Blood
; 2024 Feb 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38306657
2.
Efficacy of JAK1/2 inhibition in murine immune bone marrow failure.
Blood
; 141(1): 72-89, 2023 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36130301
3.
Differential diagnosis of bone marrow failure syndromes guided by machine learning.
Blood
; 141(17): 2100-2113, 2023 04 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36542832
4.
Spectrum of clonal hematopoiesis in VEXAS syndrome.
Blood
; 142(3): 244-259, 2023 07 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37084382
5.
Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.
Blood
; 139(1): 34-43, 2022 01 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34525188
6.
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
Blood
; 140(13): 1496-1506, 2022 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35793467
7.
8.
HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
Blood
; 138(26): 2799-2809, 2021 12 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34724566
9.
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy.
Haematologica
; 108(12): 3298-3307, 2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37259612
10.
Granulocyte transfusions in severe aplastic anemia.
Haematologica
; 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38058170
11.
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study.
Am J Hematol
; 98(6): 932-939, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37021397
12.
Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.
Br J Haematol
; 199(5): 679-687, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36128909
13.
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag.
Haematologica
; 107(1): 126-133, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33910334
14.
Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis.
Haematologica
; 107(8): 1815-1826, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34587721
15.
Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia.
Br J Haematol
; 192(3): 605-614, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33410523
16.
Deficit of circulating CD19+ CD24hi CD38hi regulatory B cells in severe aplastic anaemia.
Br J Haematol
; 190(4): 610-617, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32311088
17.
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome.
Haematologica
; 105(12): 2785-2794, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33256377
18.
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.
Blood
; 140(8): 927-931, 2022 08 25.
Artigo
Inglês
| MEDLINE | ID: mdl-35609174
19.
Towards treatments for VEXAS.
Br J Haematol
; 196(4): 804-805, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34729765
20.
COVID-19 infection in patients with severe aplastic anaemia.
Br J Haematol
; 193(5): 902-905, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33928632